Skip to main content

Ventas Value Stock - Dividend - Research Selection

Ventas

ISIN: US92276F1003 , WKN: 878380

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of more than 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. References to ?Ventas? or the ?Company? mean Ventas, Inc. and its consolidated subsidiaries unless otherwise expressly noted. More information about Ventas and Lillibridge can be found at www.ventasreit.com and www.lillibridge.com.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Alexandria (ARE) Beats Q1 AFFO Estimates, Narrows '24 Guidance

2024-04-23
Alexandria's (ARE) Q1 results reflect healthy leasing activity and rental rate growth.

A Hawkish Pivot

2024-04-21
US equity markets posted their worst week in a year while benchmark interest rates surged to five-month highs. Click here to read more.

Real estate stocks continue on downward trajectory as market's April pullback intensifies

2024-04-20
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

REIT Earnings Preview: Delay And Pray

2024-04-19
Get insights on the real estate market as earnings season begins, with a focus on the impact of interest rates and opportunities for REITs. Read what investors need to know.

SL Green's (SLG) Q1 FFO Beat Estimates, '24 FFO View Raised

2024-04-18
SL Green's (SLG) Q1 FFO outshines estimates. However, rental revenues and the occupancy in Manhattan's same-store office portfolio fall year over year.

Crown Castle's (CCI) Q1 AFFO Beat, Site-Rental Revenues Fall

2024-04-18
Crown Castle's (CCI) Q1 earnings outshine estimates. Site rental revenues fall year over year, hurting the top line. However, a fall in operating expenses supported the results to some extent.

Crown Castle's (CCI) Q1 AFFO & Revenues Surpass Estimates

2024-04-18
Crown Castle's (CCI) Q1 results outshine estimates on better-than-anticipated revenues. However, high interest expense is a concern. It has maintained its 2024 outlook.

Interesting VTR Put And Call Options For June 21st

2024-04-18
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting

2024-04-18
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

10 Best Alternatives to Nursing Homes and Assisted Living

2024-04-18
This article takes a look at the 10 Best Alternatives to Nursing Homes and Assisted Living. If you wish to skip our detailed analysis, you may go to 5 Best Alternatives to Nursing Homes and Assisted Living. The Evolution of Senior Living and Nursing Home Stocks Amid Demographic Shifts and Pandemic Challenges Back in 2015, […]